Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
measles, mumps, rubella and varicella vaccine (live) (Beijing Institute of Biological Products)
- Development stage
- Preclinical
- Lead developer
- Beijing Institute of Biological Products
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Subcutaneous
01
Overview
This is a live attenuated quadrivalent combination vaccine (MMRV) currently in preclinical development by the Beijing Institute of Biological Products (BJIBP). It is designed to provide simultaneous immunization against measles, mumps, rubella, and varicella (chickenpox) in a single formulation. The vaccine contains weakened forms of the measles, mumps, rubella, and varicella-zoster viruses, which work by eliciting protective immune responses, including the production of neutralizing antibodies and the activation of cell-mediated immunity against all four viral pathogens. This combination approach aims to simplify childhood immunization schedules and improve coverage for these common viral diseases.
- Other names
- 麻腮风水痘联合减毒活疫苗MMRV 联合疫苗MMRV vaccineMeasles-Mumps-Rubella-Varicella vaccine
Beyond the preview
Go deeper on measles, mumps, rubella and varicella vaccine (live) (Beijing Institute of Biological Products).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on measles, mumps, rubella and varicella vaccine (live) (Beijing Institute of Biological Products).